A 43-year-old woman with Type-2 diabetes has been taking insulin with meals as well as metformin. Her blood glucose remains poorly controlled. Her doctor prescribes an additional drug, which is an analog of an endogenous peptide that enhances insulin secretion. What drug is this?

A 43-year-old woman with Type-2 diabetes has been taking insulin with meals as well as metformin. Her blood glucose remains poorly controlled. Her doctor prescribes an additional drug, which is an analog of an endogenous peptide that enhances insulin secretion. What drug is this?

A 48-year-old female who is obese with elevated cholesterol is treated with fenofibrate for elevated cholesterol levels. She complains of acute onset of right upper quadrant pain, nausea, and vomiting after eating a fatty meal. She is brought to the emergency department for further evaluation. Which of the following is the most likely explanation for these findings?

A 44-year-old woman with a long history of diarrhea, sweating, and weight loss is thought to have hyperthyroidism. This condition can be worsened with which of the following treatments?

A 57-year-old man with Type-2 diabetes presents to the primary care clinic for follow-up. He has been taking metformin and has had good control of his sugars. He denies any hypoglycemic episodes or peripheral neuropathy. His hemoglobin \A_{1c is 8.3%, which is increased from 7.9% previously. The physician decides to add miglitol to his regimen. What is the mechanism of action of miglitol?

A 44-year-old man with Type-2 diabetes presents to the ambulatory care clinic for follow-up. He was diagnosed with diabetes 6 months ago and was started on oral medication then. His blood sugar has been under good control with a hemoglobin \A_{1c of 6.7%. He has not had any hypoglycemic episodes. His only complaint is that despite daily exercise and eating healthier, he has gained 12lb in the last 6 months. What medication is most likely to cause his weight gain?